Checkpoint Capital

Latest statistics and disclosures from Checkpoint Capital's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are ARGX, RYTM, RVMD, IRON, CYTK, and represent 98.40% of Checkpoint Capital's stock portfolio.
  • Added to shares of these 6 stocks: RYTM (+$20M), ARGX (+$8.0M), SEPN, CRNX, CYTK, TRVI.
  • Started 3 new stock positions in TRVI, CRNX, SEPN.
  • Reduced shares in these 3 stocks: CORT (-$18M), IRON (-$11M), RVMD (-$11M).
  • Sold out of its position in CORT.
  • Checkpoint Capital was a net seller of stock by $-5.7M.
  • Checkpoint Capital has $279M in assets under management (AUM), dropping by -12.95%.
  • Central Index Key (CIK): 0001977548

Tip: Access up to 7 years of quarterly data

Positions held by Checkpoint Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Checkpoint Capital

Checkpoint Capital holds 8 positions in its portfolio as reported in the March 2026 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Argenx Se Sponsored Adr (ARGX) 40.1 $112M +7% 153k 730.25
 View chart
Rhythm Pharmaceuticals (RYTM) 38.3 $107M +23% 1.2M 86.97
 View chart
Revolution Medicines (RVMD) 9.2 $26M -29% 263k 97.25
 View chart
Disc Medicine (IRON) 6.6 $18M -36% 287k 63.94
 View chart
Cytokinetics Com New (CYTK) 4.3 $12M +7% 180k 65.91
 View chart
Septerna (SEPN) 0.9 $2.4M NEW 100k 24.03
 View chart
Crinetics Pharmaceuticals In (CRNX) 0.5 $1.5M NEW 40k 36.32
 View chart
Trevi Therapeutics (TRVI) 0.2 $597k NEW 50k 11.93
 View chart

Past Filings by Checkpoint Capital

SEC 13F filings are viewable for Checkpoint Capital going back to 2023